Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.3.0.15
Consolidated Statements Of Cash Flows (USD $)
In Thousands
 9 Months Ended
Oct. 01, 2011
Oct. 02, 2010
Cash flows from operating activities:    
Net income $ 31,604 $ 15,133
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,025 5,116
(Gain)Loss on disposal of assets (27) 22
Gain on investment in HCT (1,244)  
Provision for deferred income taxes   (6)
Allowance for doubtful accounts 16 3
Stock-based compensation expense 1,218 798
Stock options income tax benefit   (32)
(Increase) decrease in, net of acquisition:    
Accounts receivable (2,927) (6,474)
Inventories (823) (1,962)
Income taxes receivable 866 1,509
Other current assets (488) (1,184)
Other assets (88) 622
Increase (decrease) in, net of acquisition:    
Accounts payable 1,534 1,994
Accrued expenses and other liabilities 3,535 1,569
Other noncurrent liabilities (202) 164
Net cash provided by operating activities 37,999 17,272
Cash flows from investing activities:    
Proceeds from sale of joint venture 1,451  
Investment in HCT, net of cash received (1,776)  
Capital expenditures (6,778) (2,060)
Proceeds from dispositions 30  
Purchases of marketable securities (10,395) (11,626)
Proceeds from sale of marketable securities 6,497 7,326
Net cash used in investing activities (10,971) (6,360)
Cash flows from financing activities:    
Proceeds from exercise of stock options 61 44
Proceeds from stock issued 408 303
Dividends to shareholders (7,284) (4,583)
Stock options income tax benefit   32
Net cash used in financing activities (6,815) (4,204)
Effect of exchange rate changes on cash and cash equivalents (706) (205)
Net increase in cash and cash equivalents 19,507 6,503
Cash and cash equivalents, beginning of period 33,337 30,446
Cash and cash equivalents, end of period 52,844 36,949
Supplemental disclosure of cash flow information:    
Income taxes 14,503 6,276
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities $ 2,412